Autophagy and treatment of patients with COVID-19;which drugs target the autophagy pathway?
Journal of Nephropathology
; 11(1), 2022.
Article
in English
| EMBASE | ID: covidwho-1553864
ABSTRACT
Autophagy is a way to create new cellular structures, clear cells invaded by microbes, and block accumulating proteins that can cause disease. Moreover, it can destroy all cellular organs and pathogens, including fungi, parasites, bacteria, and viruses, either randomly or selectively. Many research groups are examining a strategy to combat COVID-19. In particular, research is underway to identify drugs that can target autophagy in COVID-19 virus infection. Several known drugs are currently under clinical evaluation for the autophagy process, given that regulating autophagy is a way to combat COVID-19. This study introduces drugs that target the autophagy pathway.
alpha2b, interferon; aminoquinoline, derivative; angiotensin, converting, enzyme, 2; chloroquine; corticosteroid; hydroxychloroquine; lopinavir, plus, ritonavir; nelfinavir; nitazoxanide; ruxolitinib; Akt, signaling; apoptosis; article; autolysosome; autophagosome; autophagy, (cellular); cell, fusion; clinical, evaluation; coronavirus, disease, 2019; endosome; enzyme, activity; exocytosis; human; lysosome; lysosome, membrane; Severe, acute, respiratory, syndrome, coronavirus, 2; virus, replication
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Language:
English
Journal:
Journal of Nephropathology
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS